期刊文献+

新型基因重组α-半乳糖苷酶工程菌菌种稳定性研究 被引量:2

Study of Heredity Stability of a Recombinant Plasmid pET28c-α-Galactosidase in Escherichia coli
下载PDF
导出
摘要 观察脆弱类杆菌来源的新型重组α-半乳糖苷酶工程菌菌株的遗传稳定性。在有选择压力(Kan+)条件下,将重组α-半乳糖苷酶工程菌菌株在LB固体培养基上采用划线法连续传60代,每隔20代取样保存菌种,最后同时进行菌体形态、生长速度和抗生素抗性、平板传代及诱导过程中的质粒稳定性、限制酶切图谱、测序、表达量和酶活力检测。结果表明细菌形态、生长速度和抗生素抗性等与原始种子库无明显差异;LB固体培养基上传60代后质粒稳定性接近100%,但诱导过程中质粒易丢失。第20、40和60代提取质粒进行酶切检查,酶切图谱没有改变。DNA测序未见α-半乳糖苷酶基因变异。原代菌株及第20、40和60代菌株经诱导培养,其α-半乳糖苷酶表达水平、酶活力及菌体蛋白的SDS-PAGE图谱均无明显差异。 This study aimed to investigate the heredity stability of recombinant plasmid(pET28c-α-galactosidase)in host cell(BL21(DE3)).Samples were collected every 20 generations.Bacteria shape,growth rate,antibiotic resistance,plasmid stability,restriction map,sequencing,expressing level,and activity were analyzed.The results showed that all of the index was similar to the origin one,which indicated that recombinant stain,pET28c-α-galactosidase /BL21(DE3)had a high hereditable stability.
出处 《生物技术通报》 CAS CSCD 北大核心 2011年第7期201-204,共4页 Biotechnology Bulletin
关键词 重组α-半乳糖苷酶 遗传稳定性 传代 Recombinant α-galactosidase Heredity stability Generations
  • 相关文献

参考文献8

二级参考文献32

共引文献45

同被引文献22

  • 1Wang F, Ren J, Qiu XC, et al. Selective cytotoxicity tn HER2-posi- rive tumor cells by a recombinant e23sFv-TD-tBID protein containing a furin cleavage sequence[ J ]. Clin Cancer Res, 2010, 16 ( 8 ) : 2284 - 2294.
  • 2Ren JL, Meng YL, Hu B, et al. The effect of direct translocation across endosomes on the cytotuxicity of the recombinant protein e23sFv-Fdt-casp6 to HER2 positive gastric cancer cells [ J ]. Biomate- rials, 2011, 32 (30) : 7641 - 7650.
  • 3Qiu xc, Xu YM, Wang F, et al. Single-chain antibody/activated BID chimeric protein effectively suppresses HER2-positive tumor growth [J]. Mol Cancer Ther, 2008, 7(7) : 1890 - 1899.
  • 4Akbar S M, Hiasa Y, Mishiro S, et al. Treatment of hepatitis B virus-infected patients: utility of therapeutic recommendations in developing countries [ J ]. Expert Opin Pharmacother, 2009, 10 (10) : 1605 - 1614.
  • 5Lu J J, Chen E Q, Yang J H, et al. A mutation in the interferon regulatory element of HBV may influence the response of interferon treatment in chronic hepatitis B patients[J]. Virol J, 2012, 9:10.
  • 6Zhu Y, Qin B, Xiao C, et al. Cell-type specific interferon stimulated gene staining in liver underlies response to interferon therapy in chronic HBV infected patients[J]. Dig Dis Sci, 2012, 57:2355 -2361.
  • 7Stel' makh V V. Possibilities of using interferon-induction therapy during latent HBV infection [ J ]. Eksp Klin Farmakol, 201l, 7d :35 - 39.
  • 8Ren S, Yu H, Zhang H, et al. Polymorphisms of interferon-inducible genes OAS associated with interferon-alpha treatment response in chronic HBV infection[J]. Antiviral Res, 2011, 89:232 - 237.
  • 9Okunev O V, Gil'chuk P V, Irodov D M, et al. Production and characterization of the single chain antibodies against human alpha2b- interferon[J]. Ukr Biokhim Zh, 2005, 77(5) : 106 - 115.
  • 10Sonneveld M J, Rijckborst V, Cakaloglu Y, et al. Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-alpha2b: relation to response and HBV genotype[J]. Antivir Ther, 2012, 17:9 -17.

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部